NOVABAY PHARMACEUTICALS INC's ticker is NBY and the CUSIP is 66987P201. A total of 21 filers reported holding NOVABAY PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $37,000 | -40.3% | 57,069 | -37.9% | 0.00% | – |
| Q2 2021 | $62,000 | -6.1% | 91,917 | +25.8% | 0.00% | – |
| Q1 2021 | $66,000 | +15.8% | 73,058 | -10.1% | 0.00% | – |
| Q4 2020 | $57,000 | +256.2% | 81,298 | +271.7% | 0.00% | – |
| Q3 2020 | $16,000 | -66.0% | 21,872 | -46.8% | 0.00% | – |
| Q2 2020 | $47,000 | +213.3% | 41,136 | +232.3% | 0.00% | – |
| Q1 2019 | $15,000 | – | 12,378 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Virtu Financial LLC | 52,301 | $36,000 | 0.00% |
| TOWNSQUARE CAPITAL LLC | 53,672 | $37,000 | 0.00% |
| REILLY FINANCIAL ADVISORS, LLC | 17,500 | $12,000 | 0.00% |
| NVWM, LLC | 2,997 | $2,000 | 0.00% |
| Advisory Services Network, LLC | 20,500 | $14,000 | 0.00% |
| VANGUARD GROUP INC | 160,224 | $112,000 | 0.00% |
| UBS Group AG | 10,353 | $7,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 25,000 | $17,000 | 0.00% |
| Sugarloaf Wealth Management, LLC | 2,000 | $1,000 | 0.00% |
| OSAIC HOLDINGS, INC. | 3,260 | $3,000 | 0.00% |